Facts
- Winchester manufactured and sold medicinal vegetable extracts under his trade labels.
- A jar containing extract of belladonna (a deadly poison) was falsely labeled as “extract of dandelion” (a relatively harmless medicine).
- Winchester sold the mislabeled jar to a New York druggist (Aspinwall), who resold it to an upstate physician/druggist (Dr. Foord).
- Mrs. Thomas’s physician prescribed dandelion; Mr. Thomas bought “dandelion” from Dr. Foord, who dispensed from the mislabeled jar.
- Mrs. Thomas ingested belladonna, became violently ill, and suffered serious injury.
- Belladonna and dandelion closely resembled one another, making correct labeling critical for safe use.
Issues
- Whether a manufacturer who mislabels a poisonous medicine owes a duty of care in negligence to an injured consumer lacking contractual privity.
- Whether placing a mislabeled poison into commerce is an “imminently dangerous” act creating a duty to remote purchasers and users.
- Whether negligence by intermediate sellers or dispensers severs proximate causation or bars recovery against the manufacturer.
Decision
- The New York Court of Appeals affirmed a plaintiff’s verdict awarding damages for Mrs. Thomas’s injuries.
- The court held Winchester owed a duty of care extending beyond his immediate vendee because mislabeling a poison as a harmless drug creates imminent danger to human life.
- The absence of privity did not bar recovery where the defendant’s conduct created a direct risk of serious bodily harm to foreseeable users.
- Intermediary conduct did not absolve Winchester where his mislabeling was a direct and concurring cause of the injury.
Legal Principles
- A defendant who negligently places into commerce an article dangerous to human life, falsely represented as safe, may be liable to foreseeable injured persons without contractual privity.
- When the negligent act itself creates imminent danger of serious bodily harm, the duty is imposed by tort law and extends to those foreseeably exposed to the danger.
- The chain of distribution does not necessarily break proximate cause; negligent mislabeling of a dangerous product can remain an operative, concurring cause at the time of injury.
- Liability is not limited to “ordinary” negligent performance of a contract when the conduct involves a poison or similarly dangerous article likely to reach and injure remote users relying on the representation.
Conclusion
The court held that a manufacturer who sends a mislabeled poison into the market owes a duty of reasonable care to remote purchasers and consumers foreseeably endangered by the label, and may be liable for resulting injuries notwithstanding lack of privity or intervening distribution.